New drug research and development are the core activities of the pharmaceutical industry.The successful discovery and development of new drugs that are effective for diseases requires interdisciplinary cooperation,massive investments,and continuous pursuit of innovation.In recent years,the global evolution of new drug research and experimental development(R&D)and competition landscape has accelerated.In China,many innovative pharmaceutical companies were also seeking in-depth changes,and transformational developments,and accelerated their overseas expansion.In 2023,the number of innovative drugs approved for marketing in the world continued to grow,with a year-on-year increase of 17％.The number of clinical research pipelines also continued to expand.In this review,we summarized and provided insights into future development trends in light of the rise of biotechnology and gene therapy,the gradual increase in drug research and development for rare diseases,and the significant progress of research and development in the field of immunotherapy.From the perspective of the categories of innovative drugs and the new pattern of R&D status,we sorted out the development trends of new drugs in 2023 and prospect the future trends in this field.
innovative drugscell and gene therapyCROdigital technologydrug delivery
NETL
NSTL
万方数据
